Press Releases | Arnold Ventures

Congressional Leaders Can Cut up to $1T in Waste, Fraud and Abuse by Addressing Overpayments to Medicare Advantage Plans and Enacting Site-Neutral Payments

06.05.2025

Arnold Ventures: Congress Should Enact Health Reforms Over Harmful Cuts

05.12.2025

NEW POLL: Majority of Americans Support Lower Drug Prices, Demand Congress Act

04.22.2025

2026 Medicare Advantage and Part D Rates Include $25 Billion Increase to Health Insurers

04.08.2025

Lower Federal Spending by Cutting Unnecessary Health Care Costs, Not Coverage

04.07.2025

Congress Should Lower Health Costs and Enact Site Neutral Payment Reforms.

02.28.2025

Inclusion of Billing Transparency and Patent Reform in End-of-Year Spending Package a Win for Americans

12.17.2024

Sens. Cassidy and Hassan Release Bipartisan Site-Neutral Payment Reform Framework

11.01.2024

Arnold Ventures Optimistic Upon Seeing the First Round of Medicare Negotiated Drug Prices Announced

08.15.2024

Arnold Ventures Commends Senate on Unanimous Passage of the Affordable Prescriptions for Patients Act

07.11.2024

Meaningful Reforms Need to be Enacted Sooner Rather Than Later to Protect Medicare Program

05.07.2024

Arnold Ventures Applauds CMS’ Efforts to Rein in Medicare Advantage Costs, Notes 2025 Medicare Rates Include $16 Billion Increase in Plan Payments

04.03.2024

12 Million Vulnerable Seniors Could See Improved Access to Health Care with New Bipartisan Legislation

03.14.2024

Statement from Arnold Ventures Executive Vice President of Health Care, Mark E. Miller on the Release of the No Surprises Act IDR Reports

02.16.2024

Statement from Arnold Ventures Executive Vice President of Health Care, Mark E. Miller on the Additional $16 Billion in Plan Payments in Proposed Medicare Advantage and Part‑D Rate Notice

02.01.2024

Statement From Arnold Venture’s Mark E. Miller on the U.S. House of Representatives Passage of the Lower Costs, More Transparency Act, a Critical Step Forward in Addressing Rising Health Care Costs

12.12.2023

Health Policy Leaders Launch Coalition to Protect Consumers and Employers from Predatory Health Care Pricing

09.13.2023

New Law Goes Into Effect to Strengthen The Maryland Prescription Drug Affordability Board

04.11.2023

Statement from Arnold Ventures’ Mark E. Miller on Biden Administration’s Decision to Slow Implementation of Medicare Advantage Reforms

03.31.2023

California Selects Civica Rx as Its Insulin Manufacturing Partner

03.20.2023

New Survey Shows Americans Overwhelmingly Believe Congress and the Administration Should Crack Down on Medicare Advantage Insurers for Abusive Billing Practices

03.20.2023

Statement on the Biden Administration’s Final Regulations to Implement the No Surprises Act

08.19.2022

Statement from Laura and John Arnold on Landmark Law to Lower Prescription Drug Prices

08.16.2022

Statement from Laura and John Arnold Following Senate Passage of the Inflation Reduction Act of 2022

08.07.2022